Compounds > aspirin

aspirin and ranolazine

aspirin has been researched along with ranolazine in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (14.29)	18.2507
2000's	1 (14.29)	29.6817
2010's	3 (42.86)	24.3611
2020's	2 (28.57)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Bueno, O; Zavecz, JH	1
Armstrong, PW; Borer, JS; Fleming, T; Nissen, SE	1
Battler, A; Dvir, D	1
Davangeri, R; Hashilkar, NK; Majagi, SI; Naveena, R	1
Hayashi, S; Kanda, Y; Ono, A; Satsuka, A; Yanagida, S	1

Reviews

3 review(s) available for aspirin and ranolazine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Pharmacologic therapy of angina pectoris. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1995, Volume: 147, Issue:5 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Aspirin; Calcium Channel Blockers; Drug Therapy, Combination; Enoximone; Heparin; Humans; Isosorbide Dinitrate; Niacinamide; Nicorandil; Nitroglycerin; Piperazines; Ranolazine; Vasodilator Agents	1995
Conventional and novel drug therapeutics to relief myocardial ischemia. Cardiovascular drugs and therapy, 2010, Volume: 24, Issue:4 Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Benzazepines; Calcium Channel Blockers; Cardiovascular Agents; Cardiovascular System; Coronary Artery Disease; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Nicorandil; Nitrates; Piperazines; Ranolazine	2010

Other Studies

4 other study(ies) available for aspirin and ranolazine

Article	Year
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Report from the 100th Cardiovascular and Renal Drugs Advisory Committee meeting: US Food and Drug Administration: December 8-9, 2003 Gaithersburg, MD. Circulation, 2004, Jan-20, Volume: 109, Issue:2 Topics: Acetanilides; Angina Pectoris; Aspirin; Clinical Trials as Topic; Delayed-Action Preparations; Drug Labeling; Humans; Maryland; Myocardial Infarction; Piperazines; Ranolazine	2004
Effect of anti-inflammatory activity of ranolazine in rat model of inflammation. The Indian journal of medical research, 2018, Volume: 148, Issue:6 Topics: Acute Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carrageenan; Edema; Granuloma, Foreign-Body; Gum Arabic; Inflammation; Male; Random Allocation; Ranolazine; Rats, Wistar	2018
Proarrhythmia Risk Assessment Using Electro-Mechanical Window in Human iPS Cell-Derived Cardiomyocytes. Biological & pharmaceutical bulletin, 2022, Volume: 45, Issue:7 Topics: Aspirin; Bepridil; DNA-Binding Proteins; Humans; Induced Pluripotent Stem Cells; Mexiletine; Myocytes, Cardiac; Ranolazine; Risk Assessment	2022